A serious complication of selected internal radiation therapy: Case report and literature review

Oncologist

Volumn 15, Issue 8, 2010, Pages 830-835

  Sjoquist, Katrin M ^a   Goldstein, David ^a,b   Bester, Lourens ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Literature review; Liver neoplasms; Peptic ulcer; Radiopharmaceuticals

Indexed keywords

ADRENALIN; ALBUMIN; BEVACIZUMAB; ESOMEPRAZOLE; FLUOROURACIL; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEPARIN; IRINOTECAN; WARFARIN; YTTRIUM 90;

ADULT; BACTERIAL ENDOCARDITIS; CANCER RECURRENCE; CASE REPORT; COLON ADENOCARCINOMA; COLON RESECTION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE TRANSFUSION; FEVER; GASTRECTOMY; GASTRIC ULCER BLEEDING; GASTROSCOPY; HEART FAILURE; HEMIHEPATECTOMY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETHARGY; LIVER ANGIOGRAPHY; LIVER ARTERIOGRAPHY; LIVER METASTASIS; MALE; MELENA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRESYNCOPE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RADIOTHERAPY; REVIEW; SELECTED INTERNAL RADIATION THERAPY; STOMACH ULCER; THERMOCOAGULATION; THROMBOCYTE COUNT; WOUND HEALING IMPAIRMENT;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; RADIATION INJURIES; STOMACH ULCER; YTTRIUM RADIOISOTOPES;

EID: 77956851440     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0074     Document Type: Review

References (24)

1. van Hazel GA, Pavlakis N, Goldstein D et al. Treatment of fluorouracilrefractory patients with liver metastases from colorectal cancer by using yttrium- 90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 2009;27:4089-4095.
2. Kuebler JP. Radioembolization of liver metastases in patients with colorectal cancer: A nonsurgical treatment with combined modality potential [editorial]. J Clin Oncol 2009;27:4041-4042.
3. Riaz A, Ryu RK, Kulik LM et al. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: Oncologic marker of radiologic response, progression, and survival. J Clin Oncol 2009;27:5734-5742.
4. Kennedy AS, McNeillie P, Dezarn WA et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009; 74:1494-1500.
5. Salem R, Lewandowski RJ, Mulcahy MF et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: A comprehensive report of long-term outcomes. Gastroenterology 2010;138:52-64.
6. Townsend A, Price T, Karapetis C. Selective internal radiation therapy for liver metastases from colorectal cancer. Cochrane Database Syst Rev 2009(4):CD007045.
7. King J, Quinn R, Glenn DM et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113:921-929.
8. Reardon KA, McIntosh AF, Shilling AT et al. Treatment of primary liver tumors with yttrium-90 microspheres (TheraSphere) in high risk patients: Analysis of survival and toxicities. Technol Cancer Res Treat 2009;8:71-77.
9. Van De Wiele C, Defreyne L, Peeters M et al. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors. Q J Nucl Med Mol Imaging 2009;53:317-324.
10. Michael M, Vancutsem E, Kretzschmar A et al. Feasibility of metastasectomy in patients treated with bevacizumab in first-line mCRC - Preliminary results from the First Beat-study. J Clin Oncol 2006;24(18 suppl):3523.
11. Sirtex Medical. SIR-Spheres_ [package insert]. Available at http://www.sirtex.com/files/US20Package20Insert1.pdf, accessed July 27, 2010.
12. Konda A, Savin MA, Cappell MS et al. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: An underrecognized clinical entity. Gastrointest Endosc 2009;70:561-567.
13. Murthy R, Brown DB, Salem R et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007;18:553-562.
14. Szyszko T, Al-Nahhas A, Tait P et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 2007;28:21-24.
15. Sharma RA, Van Hazel GA, Morgan B et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099-1106.
16. Riaz A, Lewandowski RJ, Kulik LM et al. Complications following radioembolization with yttrium-90 microspheres:Acomprehensive literature review. J Vasc Interv Radiol 2009;20:1121-1130; quiz 1131.
17. Sato KT, Lewandowski RJ, Mulcahy MF et al. Unresectable chemorefractory liver metastases: Radioembolization with 90Y microspheres-safety, efficacy, and survival. Radiology 2008;247:507-515.
18. Kennedy A, Nag S, Salem R et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007;68:13-23.
19. Salem R, Lewandowski RJ, Sato KT et al. Technical aspects of radioembolization with 90Ymicrospheres. Tech Vasc Interv Radiol 2007;10:12-29.
20. Song S-Y, Chung JW, Lim HG et al. Nonhepatic arteries originating from the hepatic arteries: Angiographic analysis in 250 patients. J Vasc Interv Radiol 2006;17:461-469.
21. Silvanto A, Novelli M, Lovat L. SIRT-an uncommon cause of gastroduodenal ulceration. Histopathology 2009;55:114-115.
22. South CD, Meyer MM, Meis G et al. Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 2008;6:93-99.
23. Zimmermann L, Dudeck O, Schmitt J et al. Duodenal ulcer due to yttrium microspheres used for selective internal radiation therapy of hepatocellular cancer. Gastrointest Endosc 2009;69:977-978.
24. Newland LR, Walsh A, Gilbert DR et al. Selective internal radiation therapy: Acase of SIR-Sphere associated duodenal ulceration. Pathology 2007; 39:526-528.